Melatonin metabolite levels in workers exposed to 60-Hz magnetic fields: Work in substations and with 3-phase conductors

Journal of Occupational and Environmental Medicine

Volumn 42, Issue 2, 2000, Pages 136-142

  Burch, James B ^a   Reif, John S ^a   Noonan, Curtis W ^a   Yost, Michael G ^b  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 HYDROXYMELATONIN O SULFATE; MELATONIN;

ADULT; ARTICLE; CONDUCTOR; FEMALE; HEALTH HAZARD; HUMAN; MAGNETIC FIELD; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; URINE LEVEL; WORKPLACE;

EID: 0033964391     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/00043764-200002000-00006     Document Type: Article

References (51)

1. Panzer A, Viljoen M. The validity of melatonin as an oncostatic agent. J Pineal Res. 1997;22:184-202.
2. Blask DE. Melatonin in oncology. In: Yu H, Reiter RJ, eds. Melatonin Biosynthesis, Physiological Effects, and Clinical Applications. Boca Raton: CRC Press; 1993:447-475.
3. Fraschini F, Demartini G, Esposti D, Scaglione F. Melatonin involvement in immunity and cancer. Biol Signals Recept. 1998;7:61-72.
4. Conti A, Maestroni GJM. The clinical neuro-immunotherapeutic role of melatonin in oncology. J Pineal Res. 1995;19: 103-110.
5. Reiter RJ, Melchiorri D, Sewerynek E, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res. 1995;18:1-11.
6. Reiter RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol. 1998;56:359-38.
7. Savitz DA. Overview of epidemiological research on electric and magnetic fields and cancer. Am Ind Hyg Assoc J. 1993; 54:197-204.
8. Kheiffets LI, Abdelmonem AA, Buffler PA, Zhang ZW. Occupational electric and magnetic field exposure and brain cancer: a meta-analysis. J Occ Environ Med. 1995;37:1327-1341.
9. Brezinski A. Melatonin in humans. New Engl J Med. 1997;336:186-195.
10. Reiter RJ. Alterations of the circadian melatonin rhythm by the electromagnetic spectrum: a study in environmental toxicology. Reg Toxicol Pharmacol. 1992; 15:226-244.
11. Waldhauser F, Weizenbacher G, Tatzer E, et al. Alterations in nocturnal serum melatonin levels in humans with growth and aging. J Clin Endocr Metab. 1988; 66:648-652.
12. Touitou Y, Fevre M, Lagoguey M, et al. Age- and mental health-related circadian rhythms of plasma levels of melatonin, prolactin, luteinizing hormone and follicle-stimulating hormone in man. J Endocr. 1981;91:467-475.
13. Bojkowski CJ, Arendt JA, Shin MC, Markey SP. Melatonin secretion in humans assessed by measuring its metabolite, 6-sulfatoxymelatonin. Clin Chem. 1987;33:1343-1348.
14. Bartsch C, Bartsch H, Schmidt A, Ilg S, Bichler KH, Fluechter SH. Melatonin and 6-sulfatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta. 1992; 209:153-167.
15. Reiter RJ. Melatonin in the context of the reported bioeffects of environmental electromagnetic fields. Bioelectrochem Bioenergetics. 1998;47:135-142.
16. Brainard GC, Kavet R, Kheifets LI. The relationship between electromagnetic field and light exposures to melatonin and breast cancer risk: a review of the relevant literature. J Pineal Res. 1999;26: 65-100.
17. Burch JB, Reif JS, Yost MG, Keefe TJ, Pitrat CA. Nocturnal excretion of a urinary melatonin metabolite in electric utility workers. Scand J Work Environ Health. 1998;24:183-189.
18. Burch JB, Reif JS, Yost MG, Keefe TJ, Pitrat CA. Reduced excretion of a melatonin metabolite in workers exposed to 60 Hz magnetic fields. Am J Epidemiol. 1999;150:27-36.
19. Kaune W, Davis S, Stevens R Relation Between Residential Magnetic Fields, Light-at-Night, and Nocturnal Urine Melatonin Levels in Women. Palo Alto, CA: Electric Power Research Institute; 1997. TR-107242-V1, EPRI Report.
20. Pfluger DH, Minder CE. Effects of exposure to 16.7 Hz magnetic fields on urinary 6-hydroxymelatonin sulfate excretion of Swiss railway workers. J Pineal Res. 1996;21:91-100.
21. Wilson BW, Wright CW, Morris JE, et al. Evidence for an effect of ELF electromagnetic fields on human pineal gland function. J Pineal Res. 1990;9:259-269.
22. Arnetz BB, Berg M. Melatonin and adrenocorticotropic hormone levels in video display unit workers during work and leisure. J Occup Med. 1996;38: 1108-1110.
23. National Institute of Environmental Health Sciences. Assessment of Health Effects from Exposure to Power-Line Frequency Electric and Magnetic Fields. Portier CJ, Wolfe MS, eds. Research Triangle Park, NC: US Dept. Health and Human Services; 1998:311-313. Pub No. 98-3981.
24. Kato M, Honma K, Shigemitsu T, Shiga Y. Effects of circularly polarized 50-Hz magnetic field on plasma and pineal melatonin levels in rats. Bioelectromagnetics. 1993;14:97-106.
25. Kato M, Honma K, Shigemitsu T, Shiga Y. Circularly polarized 50-Hz magnetic field exposure reduces pineal gland and blood melatonin concentrations in Long-Evans rats. Neurosci Lett. 1994;166:59-62.
26. Kato M, Honma K, Shigemitsu T, Shiga Y. Horizontal or vertical 50-Hz 1-μT magnetic fields have no effect on pineal gland or plasma melatonin concentration of albino rats. Neurosci Lett. 1994;168: 205-208.
27. Kato M, Shigemitsu T. Effects of 50-Hz magnetic fields on pineal function in the rat. In: Stevens RG, Wilson BW, Anderson LE, eds. The Melatonin Hypothesis. Columbus, OH: Batelle Press; 1997:337-376.
28. Deno DW. Transmission line fields. IEEE Trans Power Appar Sys. 1976;95: 1600-1611.
29. Dietrich FM, Feero WE, Robertson DC, Sicree RM. Measurement of Power System Magnetic Fields by Waveform Capture. Palo Alto, CA: Electric Power Research Institute; 1992. TR-100061 EPRI Report.
30. Arendt J, Bojkowski C, Franey C, Wright J, Marks V. Immunoassay of 6-hydroxymelatonin sulfate in human plasma and urine: abolition of the urinary 24-hour rhythm with atenolol. J Clin Endocr Metab. 1985;60:1166-1173.
31. Aldous ME, Arendt J. Radioimmunoassay for 6-sulphatoxymelatonin in urine using an iodinated tracer. Ann Clin Biochem. 1988;25:298-303.
32. Yost MG. Alternative magnetic field exposure metrics: occupational measurements in trolley workers. Radiation Protection and Dosimetry. 1999;83:99-106.
33. Litovitz TA, Penafiel M, Krause D, Zhang D, Mullins JM. The role of temporal sensing in bioelectromagnetic effects. Bioelectromagnetics. 1997;18: 388-395.
34. Kruglikov IL, Dertinger H. Stochastic resonance as a possible mechanism of amplification of weak electric signals in living cells. Bioelectromagnetics. 1994; 15:539-547.
35. Selmaoui B, Touitou Y. Sinusoidal 50 Hz magnetic fields depress rat pineal NAT activity and serum melatonin. Role of duration and intensity of exposure. Life Sci. 1995;57:1351-1358.
36. Loescher W, Wahnschaffe U, Mevissen M, Lerchl A, Stamm A. Effects of weak alternating magnetic fields on nocturnal melatonin production and mammary carcinogenesis in rats. Oncology. 1994;51: 288-295.
37. Mevissen M, Lerchl A, Loescher W. Study of pineal function and DMBA-induced breast cancer formation in rats during exposure to a 100-mG, 50 Hz magnetic field. J Toxicol Environ Health. 1996;48:169-185.
38. Yellon SM. Acute 60 Hz magnetic field exposure effects on the melatonin rhythm in the pineal and circulation of the adult Djungarian hamster. J Pineal Res. 1994; 16:136-144.
39. Loescher W, Mevissen M, Lerchl A. Exposure of female rats to a 100-μT 50 Hz magnetic field does not induce consistent changes in nocturnal levels of melatonin. Radiat Res. 1998;150:557-567.
40. John TM, Liu GY, Brown GM. 60 Hz magnetic field exposure and urinary 6-sulfatoxymelatonin levels in the rat. Bioelectromagnetics. 1998;19:172-180.
41. Heikkinen P, Kumlin T, Laitinen JT, Komulainen H, Juutilainen J. Chronic exposure to 50-Hz magnetic fields or 900-MHz electromagnetic fields does not alter nocturnal 6-hydroxymelatonin sulfate secretion in CBA/S mice. Electro- and Magnetobiology. 1999;18:33-42.
42. Truong H, Yellon SM. Effect of various acute 60 Hz magnetic field exposures on the nocturnal melatonin rise in the adult Djungarian hamster. J Pineal Res. 1997; 22:177-183.
43. Lee JM, Stormshak F, Thompson JM, Hess DL, Foster DL. Melatonin and puberty in female lambs exposed to EMF: a replicate study. Bioelectromagnetics 1995;16:119-23.
44. Graham C, Cook MR, Riffle DW, Gerkovich MM, Cohen HD. Nocturnal melatonin levels in human volunteers exposed to intermittent 60 Hz magnetic fields. Bioelectromagnetics, 1996;17:263-273.
45. Graham C, Cook MR, Riffle DW. Human melatonin during continuous magnetic field exposure. Bioelectromagnetics. 1996;18:166-171.
46. Selmaoui B, Lambrozo J, Touitou Y. Magnetic fields and pineal function in humans: evaluation of nocturnal exposure to extremely low frequency magnetic fields on serum melatonin and urinary 6-sulfatoxymelatonin circadian rhythms. Life Sci. 1996;58:1539-1549.
47. Wood AW, Armstrong SM, Sait ML, Devine L, Martin MJ. Changes in human plasma melatonin profiles in response to 50 Hz magnetic field exposure. J Pineal Res. 1998;25:116-127.
48. Karasek M, Woldanska-Okonska M, Czernicki J, Zylinska K, Swietoslawski J. Chronic exposure to 2.9 mT, 40 Hz magnetic field reduces melatonin concentrations in humans. J Pineal Res. 1998; 25:240-244.
49. Furse CM, Gandhi OP. Calculation of electric fields and currents induced in a millimeter-resolution human model at 60 Hz using the FDTD method. Bioelectromagnetics. 1998;19:293-299.
50. Burch JB, Reif JS, Yost MG. Geomagnetic disturbances are associated with reduced nocturnal excretion of a melatonin metabolite in humans. Neurosci Lett. 1999;266:209-212.
51. Bowman JD, Methner MM. Hazard Surveillance for Workplace Magnetic Fields: Field Characteristics from Waveform Measurements. Cinncinati, OH: National Institute of Occupational Safety and Health; 1998. Report to the U S Dept. of Energy for Interagency Agreement No. DE-AI01-94CE34008.